BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4043110)

  • 1. Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2).
    Jackson PC; Pitcher EM; Davies JO; Davies ER; Sadowski CS; Staddon GE; Stirrat GM; Sunderland CA
    Eur J Nucl Med; 1985; 11(1):22-8. PubMed ID: 4043110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radionuclide imaging of ovarian tumours with 123I-labelled monoclonal antibody (NDOG2) directed against placental alkaline phosphatase.
    Davies JO; Davies ER; Howe K; Jackson PC; Pitcher EM; Sadowski CS; Stirrat GM; Sunderland CA
    Br J Obstet Gynaecol; 1985 Mar; 92(3):277-86. PubMed ID: 3978058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of radiolabelled monoclonal antibodies to human milk fat globule membrane antigens in antibody-guided tumour imaging, and administration of therapeutic dose of labelled antibody in wide-spread ovarian carcinoma. A preliminary report.
    Ashorn R; Ashorn P; Punnonen R; Pöyhönen L; Turjanmaa V; Koskinen M; Helle M; Uusitalo A; Pystynen P; Krohn K
    Ann Chir Gynaecol Suppl; 1985; 197():5-10. PubMed ID: 3863532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical applications of a monoclonal antibody (NDOG2) against placental alkaline phosphatase in ovarian cancer.
    Davies JO; Davies ER; Howe K; Jackson P; Pitcher E; Randle B; Sadowski C; Stirrat GM; Sunderland CA
    J R Soc Med; 1985 Nov; 78(11):899-905. PubMed ID: 3906119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radionuclide imaging of epithelial ovarian tumours with 123I-labelled monoclonal antibody (H317) specific for placental-type alkaline phosphatase.
    Critchley M; Brownless S; Patten M; McLaughlin PJ; Tromans PM; McDicken IW; Johnson PM
    Clin Radiol; 1986 Mar; 37(2):107-12. PubMed ID: 3698490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution, pharmacokinetics and imaging of 131I-labelled OC125 in ovarian cancer.
    Haisma HJ; Moseley KR; Battaile AI; Griffiths TC; Zurawski VR; Knapp RC
    Int J Cancer Suppl; 1988; 2():109-13. PubMed ID: 3162437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of iodine-123-labelled tumour-associated monoclonal antibodies to ovarian, breast, and gastrointestinal tumours.
    Epenetos AA; Britton KE; Mather S; Shepherd J; Granowska M; Taylor-Papadimitriou J; Nimmon CC; Durbin H; Hawkins LR; Malpas JS; Bodmer WF
    Lancet; 1982 Nov; 2(8306):999-1005. PubMed ID: 6127540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic perfusion: a method of enhancing relative tumor uptake of radiolabeled monoclonal antibodies.
    Wahl RL; Piko CR; Beers BA; Geatti O; Johnson J; Sherman P
    Int J Rad Appl Instrum B; 1988; 15(6):611-6. PubMed ID: 3251896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of tumours with murine and reshaped human monoclonal antibodies against placental alkaline phosphatase: immunolocalisation, pharmacokinetics and immune response.
    Kalofonos HP; Kosmas C; Hird V; Snook DE; Epenetos AA
    Eur J Cancer; 1994; 30A(12):1842-50. PubMed ID: 7880616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioimmunolocalization of human brain tumours: biodistribution of radiolabelled monoclonal antibody UJ13A.
    Richardson RB; Davies AG; Bourne SP; Staddon GE; Jones DH; Kemshead JT; Coakham HB
    Eur J Nucl Med; 1986; 12(7):313-20. PubMed ID: 3792360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour visualisation using a radiolabelled monoclonal antibody.
    Zalcberg JR; Thompson CH; Lichtenstein M; Leyden MJ; Andrews JT; Sullivan JR; McKenzie IF
    Aust N Z J Med; 1983 Dec; 13(6):571-7. PubMed ID: 6326726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radioimmunodetection of gliomas by administration of radiolabelled monoclonal antibodies. Experimental data.
    Stavrou D; Mellert W; Bilzer T; Senekowitsch R; Keiditsch E; Mehraein P
    Anticancer Res; 1985; 5(2):147-56. PubMed ID: 3994308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.
    Palm S; Enmon RM; Matei C; Kolbert KS; Xu S; Zanzonico PB; Finn RL; Koutcher JA; Larson SM; Sgouros G
    J Nucl Med; 2003 Jul; 44(7):1148-55. PubMed ID: 12843231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour-associated monoclonal antibodies for the diagnosis and assessment of ovarian cancer.
    Shepherd JH; Granowska M; Britton KE; Mather S; Epenetos AA; Ward BG; Slevin M
    Br J Obstet Gynaecol; 1987 Feb; 94(2):160-7. PubMed ID: 3828255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging of ovarian cancer with radiolabelled monoclonal antibodies.
    van Kranenburg DL; van Kroonenburgh MJ; Trimbos JB; Fleuren GJ; Pauwels EK
    Arch Gynecol Obstet; 1990; 247(3):107-16. PubMed ID: 2142403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations to the killing of tumours using radiolabelled antibodies.
    Vaughan AT; Anderson P; Dykes PW; Chapman CE; Bradwell AR
    Br J Radiol; 1987 Jun; 60(714):567-72. PubMed ID: 3620814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoscintigraphy of human ovarian cancer xenografts using a radiolabelled monoclonal antibody to human pregnancy serum-derived immune complexes.
    Murray T; Elliott AT; Wheldon TE; Whateley TL; Stimson WH
    Nucl Med Commun; 1988 Jul; 9(7):505-11. PubMed ID: 3173909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer: diagnosis using 123I monoclonal antibody in comparison with surgical findings.
    Granowska M; Shepherd J; Britton KE; Ward B; Mather S; Taylor-Papadimitriou J; Epenetos AA; Carroll MJ; Nimmon CC; Hawkins LA
    Nucl Med Commun; 1984 Aug; 5(8):485-99. PubMed ID: 6533499
    [No Abstract]   [Full Text] [Related]  

  • 19. Antibody-guided radiolocalisation of tumours in patients with testicular or ovarian cancer using two radioiodinated monoclonal antibodies to placental alkaline phosphatase.
    Epenetos AA; Carr D; Johnson PM; Bodmer WF; Lavender JP
    Br J Radiol; 1986 Feb; 59(698):117-25. PubMed ID: 3947819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of transitional cell carcinoma of the bladder with intravesically administered technetium-99m labelled HMFG1 monoclonal antibody.
    Malamitsi J; Zorzos J; Varvarigou AD; Archimandritis S; Dassiou C; Skarlos DV; Dimitriou P; Likourinas M; Zizi A; Proukakis C
    Eur J Nucl Med; 1995 Jan; 22(1):25-31. PubMed ID: 7698151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.